Synapsor
2 known investors
Ostar (欧态) develops an AI-powered continuous glucose monitoring (CGM) system, using self-developed biosensors and a wearable device to provide near-painless, continuous blood glucose tracking. It targets diabetes patients globally, offering an app with an AI assistant that generates customized glucose reports, alerts, and analysis for chronic disease management.
AI & Machine LearningDigital HealthMedical Devices
Investors · 2
In the news
Frequently asked questions
- What does Synapsor do?
- Ostar (欧态) develops an AI-powered continuous glucose monitoring (CGM) system, using self-developed biosensors and a wearable device to provide near-painless, continuous blood glucose tracking. It targets diabetes patients globally, offering an app with an AI assistant that generates customized glucose reports, alerts, and analysis for chronic disease management.
- Who are Synapsor's investors?
- Synapsor's investors include Qiming Venture Partners, Source Code Capital.